We invest solely in the life sciences — biotechnology, biopharmaceuticals, drug delivery, medical devices and related ventures. Our team brings experience, creativity and passion to every partnership, from concept to commercialization, carefully guiding the most promising technologies to market.
Working with Pappas Ventures
“We chose Pappas Ventures because we knew they could provide the type of resources needed to help us reach success. Not only were they able to offer additional capital, but also access to their network in support of management’s leadership.”
Former President, Plexxikon
“The team at Pappas Ventures is dedicated to their companies. They put in capital, energy, time and a thought process that helps their companies and management teams succeed.”
Venture Partner, Canaan Partners
“Pappas Ventures was an investor in TargeGen for eight years, through our ultimate acquisition by Sanofi. They added value far greater than the amount of their investment, and were particularly helpful with regard to business development issues.”
Former CEO, TargeGen
“Pappas Ventures has worked with me in several companies. Their partnership is invaluable because of the consistent and knowledgeable guidance towards a common goal.”
President & CEO, Anthera Pharmaceuticals
“The medical and scientific business landscape is a challenging place to navigate. Pappas Ventures has a deep set of industry relationships and knowledge that has helped us to avoid pitfalls and stay focused on our business goals.”
Former President & CEO, TyRx
“Pappas Ventures is more than just an experienced investor that really understands the healthcare sector. They add strategic value and have also played a meaningful role in raising awareness of our company in the marketplace.”
Gil Van Bokkelen, PhD
Chairman & CEO, Athersys
“The Pappas team has been active from the very beginning in shaping both the clinical and strategic direction of the company. Being able to call upon their extensive network is a real asset.”
Philippe Douville, PhD
CEO, Milestone Pharmaceuticals
“Pappas Ventures represents the best of the business. They are committed to our mission, and believe, as we do, that meeting the needs of patients creates value. They have the business acumen to help me guide this program forward.”
President & CEO, Thrasos Therapeutics
delivering superior results to investors and entrepreneurs alike. we do.
We have raised more than $420 million in capital across multiple funds.
1/3 of our companies have completed IPOs or have been successfully acquired.
We have guided the launch and/or development of over 55 life sciences companies.
Our history of success is helping build a brighter future of innovation and advanced care.
Pappas Ventures has raised four venture capital funds.
We evaluate more than 700 investment opportunities in a typical year.